Cover Image
市場調查報告書

防止尿失禁用設備:開發平台分析

Incontinence Devices - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 344641
出版日期 內容資訊 英文 278 Pages
訂單完成後即時交付
價格
Back to Top
防止尿失禁用設備:開發平台分析 Incontinence Devices - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年12月01日 內容資訊: 英文 278 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的防止尿失禁用設備·用品之開發中產品資訊相關分析,提供您臨床實驗/產品開發的整體進展,及各階段·各領域·各地區的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發的動向·產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 防止尿失禁用設備:現在正在開發的開發中產品 (各企業)

  • 防止尿失禁用設備的開發企業:開發中產品 (各開發階段)
  • 防止尿失禁用設備:各開發階段的開發中產品一覽

第5章 防止尿失禁用設備的企業·產品概要

  • American Medical Systems Holdings, Inc.
    • 開發中產品及現在進行中的臨床實驗概要
  • Applied Catheter Technologies Inc.
  • AugmentRx Medical Inc.
  • Bioring SA (Inactive)
  • BioSurfaces, Inc.
  • Boston Scientific Corporation
  • Ceragenix Pharmaceuticals, Inc. (Inactive)
  • Compactcath, Inc.
  • Continara Limited (Inactive)
  • Continental Dry-Works
  • Covalon Technologies Ltd.
  • DUALIS MedTech GmbH
  • Elidah, LLC
  • EMKinetics, Inc.
  • Endo International Plc
  • EndoStim, Inc
  • Enox Biopharma, Inc
  • Ethicon, Inc.
  • Facet Technologies, LLC
  • FLEXIPROBE LTD.
  • Floelle Inc.
  • Forconti Medical Ltd.
  • Future Path Medical Holding, LLC
  • Generic Medical Devices, Inc.
  • GR Dome Medical Ltd.
  • GT Urological, LLC
  • Jabil, Inc.
  • Kleeven International BV
  • Leto Medical, LLC
  • Lilium Otsuka Co., Ltd.
  • Marvao Medical Devices Limited
  • Medici Medical Srl
  • Medi-Globe GmbH
  • Medisse BV
  • Medtronic plc
  • MyoPowers Medical Technologies SA
  • 長崎大學
  • NexHand
  • Olympus Corporation Medical Systems
  • PercuVision LLC
  • Precision Medical Devices, Inc.
  • Prosurg, Inc.
  • Proxy Biomedical Limited
  • Quick-Med Technologies, Inc.
  • Salusion B.V.
  • Sharklet Technologies, Inc.
  • Solace Therapeutics
  • Teleflex Incorporated
  • Tengion, Inc.
  • The Feinstein Institute for Medical Research
  • The University of Utah
  • TheraNova, LLC.
  • Universitat Politecnica de Catalunya
  • University of Basel
  • University of California, San Diego
  • University of Michigan Pediatric Device Consortium
  • University of Nottingham
  • Urinary BioSolutions LLC
  • Uromedica, Inc.
  • Urova Medical Inc.
  • Urovalve, Inc.
  • Verathon Inc.
  • Vesiflo, Inc.
  • Victhom Human Bionics Inc. (Inactive)
  • Vysera Biomedical Limited
  • Xennovate Medical LLC

第6章 防止尿失禁用設備:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0280EPD

GlobalData's Medical Devices sector report, "Incontinence Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Incontinence Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Incontinence Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Incontinence Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Incontinence Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Incontinence Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 15

2 Introduction 16

  • 2.1 Incontinence Devices Overview 16

3 Products under Development 18

  • 3.1 Incontinence Devices - Pipeline Products by Stage of Development 18
  • 3.2 Incontinence Devices - Pipeline Products by Segment 19
  • 3.3 Incontinence Devices - Pipeline Products by Territory 20
  • 3.4 Incontinence Devices - Pipeline Products by Regulatory Path 21
  • 3.5 Incontinence Devices - Pipeline Products by Estimated Approval Date 22
  • 3.6 Incontinence Devices - Ongoing Clinical Trials 23

4 Incontinence Devices - Pipeline Products under Development by Companies 24

  • 4.1 Incontinence Devices Companies - Pipeline Products by Stage of Development 24
  • 4.2 Incontinence Devices - Pipeline Products by Stage of Development 27

5 Incontinence Devices Companies and Product Overview 30

  • 5.1 Applied Catheter Technologies Inc. Company Overview 30
  • 5.2 AugmentRx Medical Inc. Company Overview 31
  • 5.3 Bioring SA (Inactive) Company Overview 32
  • 5.4 Boston Scientific Corp Company Overview 33
  • 5.5 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 37
  • 5.6 Coloplast A/S Company Overview 38
  • 5.7 Continara Limited (Inactive) Company Overview 40
  • 5.8 Continental Dry-Works Company Overview 41
  • 5.9 DUALIS MedTech GmbH Company Overview 42
  • 5.10 Ecole Polytechnique de Montreal Company Overview 44
  • 5.11 Elidah, LLC Company Overview 45
  • 5.12 EMKinetics, Inc. Company Overview 46
  • 5.13 Endo International Plc Company Overview 47
  • 5.14 EndoStim Inc Company Overview 51
  • 5.15 Enox Biopharma Inc Company Overview 52
  • 5.16 Ergoresearch Ltd. Company Overview 53
  • 5.17 Ethicon Inc Company Overview 55
  • 5.18 Facet Technologies, LLC Company Overview 56
  • 5.19 FLEXIPROBE LTD. Company Overview 57
  • 5.20 Floelle Inc. Company Overview 58
  • 5.21 FocusStart LLC Company Overview 59
  • 5.22 Forconti Medical Ltd. Company Overview 60
  • 5.23 Future Path Medical Holding, LLC Company Overview 63
  • 5.24 GR Dome Medical Ltd. Company Overview 64
  • 5.25 GT Urological, LLC Company Overview 65
  • 5.26 Kleeven International BV Company Overview 70
  • 5.27 Leto Medical, LLC Company Overview 71
  • 5.28 Lilium Otsuka Co., Ltd. Company Overview 72
  • 5.29 Marvao Medical Devices Limited Company Overview 73
  • 5.30 Medici Medical Srl Company Overview 74
  • 5.31 Medi-Globe GmbH Company Overview 75
  • 5.32 Medprin Regenerative Medical Technologies Co Ltd Company Overview 76
  • 5.33 Minnesota Medical Technologies Corporation Company Overview 80
  • 5.34 MyoPowers Medical Technologies France SAS Company Overview 81
  • 5.35 Nagasaki University Company Overview 83
  • 5.36 NexHand Company Overview 84
  • 5.37 Olympus Medical Systems Corp. Company Overview 85
  • 5.38 PetVivo Holdings Inc Company Overview 86
  • 5.39 Precision Medical Devices, Inc. Company Overview 87
  • 5.40 Prosurg, Inc. Company Overview 90
  • 5.41 Proxy Biomedical Ltd Company Overview 92
  • 5.42 Quick-Med Technologies, Inc. Company Overview 93
  • 5.43 Rambam Health Care Campus Company Overview 94
  • 5.44 Salusion B.V. Company Overview 95
  • 5.45 Sharklet Technologies, Inc. Company Overview 96
  • 5.46 Solace Therapeutics Company Overview 97
  • 5.47 Suneva Medical Inc Company Overview 101
  • 5.48 Svenska Cellulosa Aktiebolaget Company Overview 102
  • 5.49 Teleflex Inc Company Overview 106
  • 5.50 Tengion Inc Company Overview 108
  • 5.51 The Feinstein Institute for Medical Research Company Overview 109
  • 5.52 The University of Utah Company Overview 112
  • 5.53 Universitat Politecnica de Catalunya Company Overview 114
  • 5.54 University of Basel Company Overview 115
  • 5.55 University of California San Diego Company Overview 116
  • 5.56 University of Michigan Pediatric Device Consortium Company Overview 117
  • 5.57 University of Nottingham Company Overview 118
  • 5.58 Urinary BioSolutions LLC Company Overview 119
  • 5.59 Uromedica Inc Company Overview 120
  • 5.60 Urova Medical Inc. Company Overview 123
  • 5.61 Urovalve, Inc. Company Overview 124
  • 5.62 Verathon Inc Company Overview 127
  • 5.63 Vesiflo, Inc. Company Overview 130
  • 5.64 Vysera Biomedical Ltd Company Overview 131
  • 5.65 Washington University in St Louis Company Overview 132
  • 5.66 Xennovate Medical LLC Company Overview 134

6 Incontinence Devices- Recent Developments 136

  • 6.1 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 136
  • 6.2 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 138
  • 6.3 Nov 15, 2016: Simavita releases home care system - AssessPLUS An incontinence solution for NDIS and Home Care Package recipients Simavita an Approved NDIS Provider 139
  • 6.4 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 139
  • 6.5 Nov 10, 2016: Zynex Announces Third Quarter 2016 Profit 140
  • 6.6 Nov 10, 2016: Bactiguard Holding: Interim report for Q3 2016 141
  • 6.7 Nov 08, 2016: Endo Reports Third Quarter 2016 Financial Results 142
  • 6.8 Nov 08, 2016: Sientra Reports Third Quarter 2016 Financial Results 144
  • 6.9 Nov 07, 2016: Endo Strengthens Leadership Team with Appointment of Two Key Executives 145
  • 6.10 Nov 07, 2016: Bactiguard Holding: New Major Order from China 146
  • 6.11 Nov 04, 2016: The third quarter sees another rise in sales and earnings at the HARTMANN GROUP 146
  • 6.12 Nov 04, 2016: Dentsply Sirona Reports Third Quarter 2016 Results 147
  • 6.13 Nov 02, 2016: Coloplast delivers full-year results in line with guidance 148
  • 6.14 Nov 01, 2016: Owens & Minor Releases 3rd Quarter 2016 Financial Results 149
  • 6.15 Oct 28, 2016: Results for the fourth quarter and the fiscal year ended June 30, 2016 - Ergoresearch reports its 2016 annual results 150
  • 6.16 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results 151
  • 6.17 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 157
  • 6.18 Oct 26, 2016: New clinical study confirms that Bactiguard coated Foley catheters reduce infections in ICU 159
  • 6.19 Oct 26, 2016: ConvaTec Raises USD1.8 Billion in IPO 160
  • 6.20 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 160
  • 6.21 Oct 25, 2016: Bard Announces Third Quarter Results 161
  • 6.22 Oct 24, 2016: Medline Creates 200 New Jobs in Georgia and Invests $60 Million to Expand Manufacturing and Distribution 162
  • 6.23 Oct 20, 2016: Endo Announces Departure of Chief Financial Officer 162
  • 6.24 Oct 20, 2016: Simavita releases progress update 163
  • 6.25 Oct 17, 2016: Bactiguard continues cooperation with the Swedish counties Kronoberg and Blekinge 165
  • 6.26 Oct 14, 2016: BC Partners, Blackstone and CVC Capital Partners May Acquire BSN medical from EQT Partners 165
  • 6.27 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs 165
  • 6.28 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 166
  • 6.29 Oct 06, 2016: User-Friendly Urinary Catheter Gets FDA Clearance 167
  • 6.30 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 167
  • 6.31 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare 167
  • 6.32 Sep 29, 2016: First Long-Term Usage Data on Patient Satisfaction With Pelvalon's Eclipse System to Be Presented at PFD WEEK 2016 168
  • 6.33 Sep 28, 2016: Two Clinical Abstracts on the Vesair Bladder Control System for Treating Stress Urinary Incontinence (SUI) to be Presented at the American Urogynecology Society(AUGS) Meeting in Denver, CO 169
  • 6.34 Sep 23, 2016: Solace Therapeutics Raises USD13 Million in Venture Financing Round 169
  • 6.35 Sep 23, 2016: Endo Names Paul Campanelli President and Chief Executive Officer 169
  • 6.36 Sep 15, 2016: PeriCoach Clinical Publication on Patient with Multiple Sclerosis and Faecal Incontinence 171
  • 6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 171
  • 6.38 Sep 14, 2016: New flexible catheter part of Coloplast growth plan 172
  • 6.39 Sep 13, 2016: Zynex Announces August Orders 172
  • 6.40 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation 173
  • 6.41 Sep 06, 2016: Sanofi Board Of Directors Provides Update 173
  • 6.42 Sep 01, 2016: The Cooper Companies CFO Gregory W. Matz to Retire; Albert G. White Named Successor in Planned Transition 173
  • 6.43 Sep 01, 2016: The Cooper Companies Announces Third Quarter 2016 Results 174
  • 6.44 Sep 01, 2016: Verathon Announces the Appointment of Tracy Olson, Vice President of Finance 174
  • 6.45 Aug 31, 2016: Simavita Reports Full Year Financial Results 175
  • 6.46 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 175
  • 6.47 Aug 29, 2016: Covalon Tech Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 175
  • 6.48 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 176
  • 6.49 Aug 22, 2016: Zynex Announces Second Quarter 2016 Results 178
  • 6.50 Aug 19, 2016: Covalon Announces Third Quarter Financial Results 179
  • 6.51 Aug 16, 2016: Zynex Announces July Orders 179
  • 6.52 Aug 16, 2016: Coloplast delivers 9M result in line with guidance 180
  • 6.53 Aug 11, 2016: Interim report for Bactiguard Holding 180
  • 6.54 Aug 10, 2016: New Major Order From India Announced By Bactiguard 183
  • 6.55 Aug 09, 2016: Sientra Reports Second Quarter 2016 Financial Results and Progress on Manufacturing Solution 184
  • 6.56 Aug 08, 2016: Endo Reports Second Quarter 2016 Financial Results 185
  • 6.57 Aug 05, 2016: Dentsply Sirona Reports Second Quarter 2016 Results 187
  • 6.58 Aug 03, 2016: PeriCoach granted patent protection in China 188
  • 6.59 Aug 03, 2016: HARTMANN GROUP continues its growth trajectory in the second quarter 188
  • 6.60 Aug 02, 2016: FDA expands use of PeriCoach at-home pelvic floor trainer device and smartphone app for sexual health 189
  • 6.61 Aug 02, 2016: Owens & Minor Reports 2nd Quarter 2016 Financial Results 190
  • 6.62 Jul 29, 2016: PeriCoach sexual health indication clarification from USFDA 192
  • 6.63 Jul 29, 2016: Sanofi Announces Q2 2016 Results 192
  • 6.64 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi 199
  • 6.65 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 200
  • 6.66 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 201
  • 6.67 Jul 28, 2016: Simavita Releases ASX Appendix 4C for the Quarter Ended June 30, 2016 203
  • 6.68 Jul 26, 2016: Bard Announces Second Quarter Results 203
  • 6.69 Jul 25, 2016: Simavita Voluntarily Delists From the Canadian TSX Venture Exchange 204
  • 6.70 Jul 22, 2016: Zynex Announces June Orders 204
  • 6.71 Jul 18, 2016: Proxy Biomedical Formally Announces Facility Expansion And Jobs Growth 204
  • 6.72 Jul 15, 2016: Torax Medical Raises USD25 Million in Series E Financing 205
  • 6.73 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 205
  • 6.74 Jul 13, 2016: Simavita Announces Appointment of Company Secretary 205
  • 6.75 Jul 12, 2016: Analytica receives FDA Over-the-Counter clearance for PeriCoach 205
  • 6.76 Jul 12, 2016: McShane Construction Company Marks Significant Progress at New 630,000 S.F. Medical Supplies Distribution Center in Phoenix, Arizona 206
  • 6.77 Jul 11, 2016: Pelvalon Names Jonathan R. Ward as Vice President of Sales 207
  • 6.78 Jul 08, 2016: Reed Construction Selected To Complete New Medline Headquarters 207
  • 6.79 Jul 06, 2016: Putting Company Culture First Spurs Growth and the Formation of Alliant Surgical Products in Grand Rapids, MI 208
  • 6.80 Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information 208
  • 6.81 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 209
  • 6.82 Jun 29, 2016: Simavita Raises USD5.4 Million in Public Offering of Shares 209
  • 6.83 Jun 27, 2016: Medline and Medic Management Group Launch New GPO Distribution Partnership 209
  • 6.84 Jun 21, 2016: MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims 210
  • 6.85 Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation's Board 210
  • 6.86 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 211
  • 6.87 Jun 07, 2016: Mayo Clinic First to Implant Device to Solve Fecal Incontinence 211
  • 6.88 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 212
  • 6.89 Jun 06, 2016: Zynex Hires Vice President of Operations 212
  • 6.90 Jun 05, 2016: Kane Biotech Announces Board Members 213
  • 6.91 Jun 02, 2016: The Cooper Companies Announces Second Quarter 2016 Results 213
  • 6.92 Jun 02, 2016: Zynex Reports Electrotherapy Orders for May 214
  • 6.93 Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation's Board of Directors 214
  • 6.94 Jun 01, 2016: Zynex Hires Vice President of Finance 214
  • 6.95 May 31, 2016: Ergoresearch announce the nomination of an Executive Vice-President 215
  • 6.96 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 215
  • 6.97 May 30, 2016: Covalon Announces Second Quarter Financial Results 217
  • 6.98 May 30, 2016: Simavita Releases Unaudited Financial Statements and MD&A for the Nine-Month Period Ended March 31, 2016 218
  • 6.99 May 27, 2016: Ergoresearch Reports its Results for the Quarter Ended March 31, 2016 218
  • 6.100 May 25, 2016: Pelvalon's Eclipse System Reviewed in Journal of Medical Devices: Evidence and Research 219
  • 6.101 May 25, 2016: Zynex Announces First Quarter 2016 Results 220
  • 6.102 May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation's Board 221
  • 6.103 May 23, 2016: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 224
  • 6.104 May 23, 2016: New Distribution Partnership for Edward-Elmhurst Health's Physician Offices Results in Cost Savings of 10 Percent 224
  • 6.105 May 19, 2016: Case Studies of PeriCoach published in Peer Reviewed Urology Journal 225
  • 6.106 May 19, 2016: Medline Inks Three-Year Prime Vendor Distribution Agreement with SBH Health System 225
  • 6.107 May 18, 2016: Renew Medical Launches New Solution to Help Prevent Accidental Bowel Leakage 226
  • 6.108 May 17, 2016: EndoStim Names Rohan Hoare, Ph.D., as New President and CEO 227
  • 6.109 May 16, 2016: Hollister Hires Carolin Archibald for Newly Created Position of Vice President of U.S. and Canada 227
  • 6.110 May 12, 2016: EndoStim Raises USD25 Million in Series D Financing 228
  • 6.111 May 12, 2016: Bactiguard Holding: Interim Report For Q1 2016 228
  • 6.112 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 229
  • 6.113 May 06, 2016: Consure Medical Raises USD4.7 Million in Series B Financing 230
  • 6.114 May 06, 2016: Simavita Announces Change to the Board 230
  • 6.115 May 05, 2016: Gynesonics Names Jiayu Chen, Ph.D., Vice President, Engineering and Advanced Technologies 230
  • 6.116 May 05, 2016: Sientra Reports First Quarter 2016 Financial Results 230
  • 6.117 May 04, 2016: C. R. Bard Prices Public Offering of 3% Notes Due 2026 for USD500 Million 231
  • 6.118 May 04, 2016: Hollister Announces Settlement Agreement 232
  • 6.119 May 04, 2016: HARTMANN GROUP gets off to a good start in 2016 with a rise in sales and earnings 232
  • 6.120 May 03, 2016: Owens & Minor Reports 1st Quarter 2016 Financial Results 233
  • 6.121 May 03, 2016: Coloplast delivers H1 result in line with expectations 234
  • 6.122 Apr 28, 2016: Teleflex Reports First Quarter 2016 Results 235
  • 6.123 Apr 27, 2016: Bard Announces First Quarter Results 236
  • 6.124 Apr 27, 2016: Simavita Announces Changes to the Board and Management; Strong Support from Existing Shareholders for the Company; Additional Financing / Issue of Notes 237
  • 6.125 Apr 20, 2016: German Court Ruling Affirms ConvaTec's Patent Protection on Flexi-Seal Fecal Management System 240
  • 6.126 Apr 18, 2016: Henry Ford Breast Cancer Program Granted 3-Year Accreditation 241
  • 6.127 Apr 13, 2016: Mayo Clinic Performs First U.S. Procedure of Novel Implant to Treat Fecal Incontinence 241
  • 6.128 Apr 05, 2016: Allegiance Health Joins Henry Ford Health System 242
  • 6.129 Mar 29, 2016: Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 242
  • 6.130 Mar 23, 2016: B. Braun's growth trend continues 243
  • 6.131 Mar 23, 2016: HARTMANN GROUP once again records profitable growth in 2015 244
  • 6.132 Mar 16, 2016: India Life Sciences Fund Invests in Biorad Medisys 245
  • 6.133 Mar 11, 2016: Teleflex Incorporated to Showcase Urological and Surgical Solutions at the European Association of Urology's 31st Annual Congress 246
  • 6.134 Mar 10, 2016: Six-month data from the SOLECT Trial awarded one of the "Best" Poster Presentations at the upcoming 31st European Association of Urology (EAU) Congress in Munich, Germany 246
  • 6.135 Mar 09, 2016: Coloplast gets breakthrough with continence business in Japan 247
  • 6.136 Mar 09, 2016: Sientra Reports Fourth Quarter and Full Year 2015 Financial Results 247
  • 6.137 Mar 03, 2016: The Cooper Companies Announces First Quarter 2016 Results 248
  • 6.138 Feb 29, 2016: Second Quarter Results ended December 31, 2015 - Ergoresearch reports its results for the quarter ended December 31, 2015 249
  • 6.139 Feb 26, 2016: Simavita Reports Half-Year Financial Results 250
  • 6.140 Feb 25, 2016: Teleflex Reports Fourth Quarter and Full Year 2015 Results; Provides 2016 Guidance 251
  • 6.141 Feb 24, 2016: Precision Medical Devices Awarded Surgical Instrument Agreement With Premier 253
  • 6.142 Feb 22, 2016: Pelvalon's Eclipse System Named Edison Awards Finalist 253
  • 6.143 Feb 17, 2016: Parasol Medical Introduces drysmart Incontinence Pad 254
  • 6.144 Feb 16, 2016: Pelvic Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports $13.5 Million Verdict Against Johnson and Johnson in Philadelphia 254
  • 6.145 Feb 16, 2016: Important Announcements and Strategy Update - Simavita 255
  • 6.146 Feb 11, 2016: Danish distributor, Abena signs first multi-site SIM deployment contract 256
  • 6.147 Feb 08, 2016: Owens & Minor Reports 4th Quarter & Full-Year 2015 Financial Results 257
  • 6.148 Feb 08, 2016: Sientra Announces Return of All Products to U.S. Market 258
  • 6.149 Feb 02, 2016: Coloplast delivers Q1 results in line with guidance 258
  • 6.150 Feb 01, 2016: Sientra Announces Executive Management Promotions 259

7 Appendix 274

  • 7.1 Methodology 274
  • 7.2 About GlobalData 277
  • 7.3 Contact Us 277
  • 7.4 Disclaimer 277

List of Tables

  • Table 1: Incontinence Devices - Pipeline Products by Stage of Development 19
  • Table 2: Incontinence Devices - Pipeline Products by Segment 20
  • Table 3: Incontinence Devices - Pipeline Products by Territory 21
  • Table 4: Incontinence Devices - Pipeline Products by Regulatory Path 22
  • Table 5: Incontinence Devices - Pipeline Products by Estimated Approval Date 23
  • Table 6: Incontinence Devices - Ongoing Clinical Trials 24
  • Table 7: Incontinence Devices Companies - Pipeline Products by Stage of Development 25
  • Table 8: Incontinence Devices - Pipeline Products by Stage of Development 28
  • Table 9: Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 10: Drug Coated Catheter - Product Status 31
  • Table 11: Drug Coated Catheter - Product Description 31
  • Table 12: AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 13: SOLVE - Product Status 32
  • Table 14: SOLVE - Product Description 32
  • Table 15: Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 16: Biowing - Product Status 33
  • Table 17: Biowing - Product Description 33
  • Table 18: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 19: Next Generation Sling System - Product Status 34
  • Table 20: Next Generation Sling System - Product Description 35
  • Table 21: Pathfinder RP - Product Status 35
  • Table 22: Pathfinder RP - Product Description 35
  • Table 23: Pathfinder TOT - Product Status 36
  • Table 24: Pathfinder TOT - Product Description 36
  • Table 25: SIS Sling System - Product Status 36
  • Table 26: SIS Sling System - Product Description 37
  • Table 27: Solyx I Sling System - Product Status 37
  • Table 28: Solyx I Sling System - Product Description 37
  • Table 29: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 30: Cerashield Coated Silicone Urinary Catheter - Product Status 38
  • Table 31: Cerashield Coated Silicone Urinary Catheter - Product Description 38
  • Table 32: Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 33: SpeediCath Flex Coude - Product Status 39
  • Table 34: SpeediCath Flex Coude - Product Description 40
  • Table 35: Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 36: UTROL Bionic Sphincter - Product Status 41
  • Table 37: UTROL Bionic Sphincter - Product Description 41
  • Table 38: Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 39: The Pocket - Product Status 42
  • Table 40: The Pocket - Product Description 42
  • Table 41: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 42: Implantable Wireless Sphincter System - Product Status 43
  • Table 43: Implantable Wireless Sphincter System - Product Description 44
  • Table 44: Ecole Polytechnique de Montreal Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 45: Bladder Implant - Product Status 45
  • Table 46: Bladder Implant - Product Description 45
  • Table 47: Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 48: Wearable Therapeutic Device - Product Status 46
  • Table 49: Wearable Therapeutic Device - Product Description 46
  • Table 50: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 51: TranStim Transdermal Neuromodulation System - Product Status 47
  • Table 52: TranStim Transdermal Neuromodulation System - Product Description 47
  • Table 53: Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 54: Accessa - Female Urge Incontinence - Product Status 48
  • Table 55: Accessa - Female Urge Incontinence - Product Description 49
  • Table 56: CONTINUUM Device - Product Status 49
  • Table 57: CONTINUUM Device - Product Description 49
  • Table 58: TOPAS Sling System - Product Status 50
  • Table 59: TOPAS Sling System - Product Description 50
  • Table 60: UroVive Self-Contained Micro-Balloon System - Product Status 51
  • Table 61: UroVive Self-Contained Micro-Balloon System - Product Description 51
  • Table 62: EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 63: Implantable Device - Urinary Incontinence - Product Status 52
  • Table 64: Implantable Device - Urinary Incontinence - Product Description 52
  • Table 65: Enox Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 66: Self-Sterilizing Urinary Catheter - Product Status 53
  • Table 67: Self-Sterilizing Urinary Catheter - Product Description 53
  • Table 68: Ergoresearch Ltd. Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 69: Urinary Disorders Implant - Product Status 54
  • Table 70: Urinary Disorders Implant - Product Description 55
  • Table 71: Ethicon Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 72: GYNECARE SUI Sling Next Generation - Product Status 56
  • Table 73: GYNECARE SUI Sling Next Generation - Product Description 56
  • Table 74: Facet Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 75: Periurethral Device - Product Status 57
  • Table 76: Periurethral Device - Product Description 57
  • Table 77: FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 78: Flexiprobe Device - Product Status 58
  • Table 79: Flexiprobe Device - Product Description 58
  • Table 80: Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 81: Floelle Device - Product Status 59
  • Table 82: Floelle Device - Product Description 59
  • Table 83: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 84: Anti-biofilm Urological Catheter - Product Status 60
  • Table 85: Anti-biofilm Urological Catheter - Product Description 60
  • Table 86: Forconti Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 87: Disposable Device - Fecal Incontinence - Product Status 61
  • Table 88: Disposable Device - Fecal Incontinence - Product Description 61
  • Table 89: Forconti Medical Ltd. - Ongoing Clinical Trials Overview 62
  • Table 90: Disposable Device - Fecal Incontinence - Safety and Effectiveness Evaluation of the ForConti Fecal Management System - Pilot Study 63
  • Table 91: Future Path Medical Holding, LLC Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 92: UroSense Essential - Product Status 64
  • Table 93: UroSense Essential - Product Description 64
  • Table 94: GR Dome Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 95: UriTop-F - Product Status 65
  • Table 96: UriTop-F - Product Description 65
  • Table 97: GT Urological, LLC Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 98: Aroyo artificial urinary sphincter - Product Status 66
  • Table 99: Aroyo artificial urinary sphincter - Product Description 66
  • Table 100: Fecal Incontinence Device - Product Status 67
  • Table 101: Fecal Incontinence Device - Product Description 67
  • Table 102: Implantable Incontinence Device - Women - Product Status 68
  • Table 103: Implantable Incontinence Device - Women - Product Description 68
  • Table 104: GT Urological, LLC - Ongoing Clinical Trials Overview 69
  • Table 105: Aroyo artificial urinary sphincter - A Prospective, Non-randomized, Multi-center Clinical Investigation of the Safety and Performance of GT UroLogIcal, LLC's ArtiFicial Urinary Sphincter (RELIEF II) 70
  • Table 106: Kleeven International BV Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 107: MAXAM Pelvic Floor Device - Product Status 71
  • Table 108: MAXAM Pelvic Floor Device - Product Description 71
  • Table 109: Leto Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 110: Continent Ostomy System - Product Status 72
  • Table 111: Continent Ostomy System - Product Description 72
  • Table 112: Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 113: Next Gen Yuririn USH-052 Scanner - Product Status 73
  • Table 114: Next Gen Yuririn USH-052 Scanner - Product Description 73
  • Table 115: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 116: NexSite Drainage Catheter - Product Status 74
  • Table 117: NexSite Drainage Catheter - Product Description 74
  • Table 118: Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 119: Time-Delayed Valve System - Product Status 75
  • Table 120: Time-Delayed Valve System - Product Description 75
  • Table 121: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 122: Incontinence Prosthesis - Product Status 76
  • Table 123: Incontinence Prosthesis - Product Description 76
  • Table 124: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 125: Regen Sling - Product Status 77
  • Table 126: Regen Sling - Product Description 78
  • Table 127: Medprin Regenerative Medical Technologies Co Ltd - Ongoing Clinical Trials Overview 79
  • Table 128: Regen Sling - A Multi-center, Randomized, Controlled Clinical Trial of the Safety and Efficacy of Regen Sling Treatment for Female Patients with Stress Urinary Incontinence 80
  • Table 129: Minnesota Medical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 130: Fecal Incontinence Management Device - Product Status 81
  • Table 131: Fecal Incontinence Management Device - Product Description 81
  • Table 132: MyoPowers Medical Technologies France SAS Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 133: ARTUS - Product Status 82
  • Table 134: ARTUS - Product Description 83
  • Table 135: Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 136: Urination Management System - Product Status 84
  • Table 137: Urination Management System - Product Description 84
  • Table 138: NexHand Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 139: Stress Urinary Incontinence Device - Product Status 85
  • Table 140: Stress Urinary Incontinence Device - Product Description 85
  • Table 141: Olympus Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 142: Uro-Ease - Product Status 86
  • Table 143: Uro-Ease - Product Description 86
  • Table 144: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 145: Female Urinary Incontinence Device - Product Status 87
  • Table 146: Female Urinary Incontinence Device - Product Description 87
  • Table 147: Precision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 148: Flow Control Device - Fecal Incontinence - Product Status 88
  • Table 149: Flow Control Device - Fecal Incontinence - Product Description 89
  • Table 150: Politano-Sayet-Sutherland Flow Control Device - Product Status 89
  • Table 151: Politano-Sayet-Sutherland Flow Control Device - Product Description 90
  • Table 152: Prosurg, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 153: ConstrictX - Product Status 91
  • Table 154: ConstrictX - Product Description 92
  • Table 155: Proxy Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 156: Biomaterial-Based Incontinence Device - Product Status 93
  • Table 157: Biomaterial-Based Incontinence Device - Product Description 93
  • Table 158: Quick-Med Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
  • Table 159: Incontinence Device - Product Status 94
  • Table 160: Incontinence Device - Product Description 94
  • Table 161: Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 162: Sensurine - Product Status 95
  • Table 163: Sensurine - Product Description 95
  • Table 164: Salusion B.V. Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 165: Home Care Incontinance Device - Product Status 96
  • Table 166: Home Care Incontinance Device - Product Description 96
  • Table 167: Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 168: Foley Urinary Catheter - Product Status 97
  • Table 169: Foley Urinary Catheter - Product Description 97
  • Table 170: Solace Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 98
  • Table 171: Vesair Bladder Control System - Product Status 98
  • Table 172: Vesair Bladder Control System - Product Description 99
  • Table 173: Solace Therapeutics - Ongoing Clinical Trials Overview 100
  • Table 174: Vesair Bladder Control System - An Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects with Stress Urinary Incontinence 101
  • Table 175: Vesair Bladder Control System - Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects with Stress Urinary Incontinence 101
  • Table 176: Suneva Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 102
  • Table 177: ArteSure - Product Status 102
  • Table 178: ArteSure - Product Description 102
  • Table 179: Svenska Cellulosa Aktiebolaget Pipeline Products & Ongoing Clinical Trials Overview 103
  • Table 180: TENA Identifi - Product Status 103
  • Table 181: TENA Identifi - Product Description 104
  • Table 182: Svenska Cellulosa Aktiebolaget - Ongoing Clinical Trials Overview 105
  • Table 183: TENA Identifi - A Randomized, Controlled Trial of Effectiveness of a Smart Sensor for Continence Care: The ARCTICC Study 106
  • Table 184: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 107
  • Table 185: Pre-Activated Female Intermittent Catheter - Product Status 107
  • Table 186: Pre-Activated Female Intermittent Catheter - Product Description 108
  • Table 187: Pre-Activated Male Intermittent Catheter - Product Status 108
  • Table 188: Pre-Activated Male Intermittent Catheter - Product Description 108
  • Table 189: Tengion Inc Pipeline Products & Ongoing Clinical Trials Overview 109
  • Table 190: Neo Bladder Augment - Urge Incontinence - Product Status 109
  • Table 191: Neo Bladder Augment - Urge Incontinence - Product Description 109
  • Table 192: The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 110
  • Table 193: Confidence Building Incontinence Pad - Product Status 110
  • Table 194: Confidence Building Incontinence Pad - Product Description 111
  • Table 195: Gelift - Product Status 111
  • Table 196: Gelift - Product Description 112
  • Table 197: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 113
  • Table 198: AdvanceCath Catheter - Product Status 113
  • Table 199: AdvanceCath Catheter - Product Description 114
  • Table 200: Urinary Assist Device - Product Status 114
  • Table 201: Urinary Assist Device - Product Description 114
  • Table 202: Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview 115
  • Table 203: Pelvic Floor Measurement Device - Product Status 115
  • Table 204: Pelvic Floor Measurement Device - Product Description 115
  • Table 205: University of Basel Pipeline Products & Ongoing Clinical Trials Overview 116
  • Table 206: Artificial Sphincter Implant - Product Status 116
  • Table 207: Artificial Sphincter Implant - Product Description 116

List of Figures

  • Figure 1: Incontinence Devices - Pipeline Products by Stage of Development 19
  • Figure 2: Incontinence Devices - Pipeline Products by Segment 20
  • Figure 3: Incontinence Devices - Pipeline Products by Territory 21
  • Figure 4: Incontinence Devices - Pipeline Products by Regulatory Path 22
  • Figure 5: Incontinence Devices - Pipeline Products by Estimated Approval Date 23
  • Figure 6: Incontinence Devices - Ongoing Clinical Trials 24
Back to Top